Multidrug-resistant Acinetobacter baumannii infection in intensive care unit patients in a hospital with building construction: Is there an association?

Korean Journal of Anesthesiology

Volumn 66, Issue 4, 2014, Pages 295-299

  Kamalbeik, Sepideh ^a   Talaie, Haleh ^b   Mahdavinejad, Arezou ^a   Karimi, Abdollah ^c   Salimi, Alireza ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acinetobacter baumannii; Integrons; Multidrug resistant; Soil

Indexed keywords

CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; TETRACYCLINE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CONSTRUCTION WORK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISK DIFFUSION; DNA EXTRACTION; FEMALE; GENOTYPE; HOSPITAL; HOSPITAL INFECTION; HUMAN; INTEGRON; INTENSIVE CARE UNIT; IRAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PHENOTYPE; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SOIL ANALYSIS; SOIL MICROFLORA;

EID: 84901285496     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2014.66.4.295     Document Type: Article

References (14)

1. Ramírez MS, Morales A, Vilacoba E, Márquez C, Centrón D. Class 2 integrons dissemination among multidrug resistance (MDR) clones of Acinetobacter baumannii. Curr Microbiol 2012; 64: 290-3.
2. Rit K, Saha R. Multidrug-resistant acinetobacter infection and their susceptibility patterns in a tertiary care hospital. Niger Med J 2012; 53: 126-8.
3. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21: 538-82.
4. Taherikalani M, Maleki A, Sadeghifard N, Mohammadzadeh D, Soroush S, Asadollahi P, et al. Dissemination of class 1, 2 and 3 integrons among different multidrug resistant isolates of Acinetobacter baumannii in Tehran hospitals, Iran. Pol J Microbiol 2011; 60: 169-74.
5. Gallego L, Towner KJ. Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain. J Med Microbiol 2001; 50: 71-7.
6. Japoni S, Japoni A, Farshad S, Ali AA, Jamalidoust M. Association between existence of integrons and multi-drug resistance in Acinetobacter isolated from patients in southern Iran. Pol J Microbiol 2011; 60: 163-8.
7. Kamalbeik S, Kouchek M, Saleh MB, Fallah F, Malekan MA, Talaie H. Prevalence of class 2 integron among multidrug-resistant Acinetobacter baumannii in toxicological ICU patients in Tehran. Iran J Toxicol 2013; 7: 900-6.
8. Koeleman BP, Herr MH, Zavattari P, Dudbridge F, March R, Campbell D, et al. Conditional ETDT analysis of the human leukocyte antigen region in type 1 diabetes. Ann Hum Genet 2000; 64: 215-21.
9. Ploy MC, Denis F, Courvalin P, Lambert T. Molecular characterization of integrons in Acinetobacter baumannii: description of a hybrid class 2 integron. Antimicrob Agents Chemother 2000; 44: 2684-8.
10. Levesque MA, D'Costa M, Angelopoulou K, Diamandis EP. Time-resolved immunofluorometric assay of p53 protein. Clin Chem 1995; 41: 1720-9.
11. Scott P, Deye G, Srinivasan A, Murray C, Moran K, Hulten E, et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis 2007; 44: 1577-84.
12. Kalenić S, Zele-Starcević L, Jarza-Davila N, Jandrlić M. Infections in war injuries. Lijec Vjesn 1991; 113: 233-5.
13. Oncül O, Keskin O, Acar HV, Küçükardali Y, Evrenkaya R, Atasoyu EM, et al. Hospital-acquired infections following the 1999 Marmara earthquake. J Hosp Infect 2002; 51: 47-51.
14. Maegele M, Gregor S, Steinhausen E, Bouillon B, Heiss MM, Perbix W, et al. The long-distance tertiary air transfer and care of tsunami victims: injury pattern and microbiological and psychological aspects. Crit Care Med 2005; 33: 1136-40.